Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.34 |
| ▸ | METAP1 | P53582 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6456826 | 0.93 | CHRNB2 (0.30) | CHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL2778338 | 0.86 | ACHE (0.34) | ACHEMETAP1CHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL6453426 | 0.80 | CHRNB2 (0.30) | CHRNB2CHRNA4 | |
| SCHEMBL4366176 | 0.75 | KDM4E (0.30) | — | |
| Hydrochloric Acid SCHEMBL151866 | 0.74 | HTR2A (0.35) | — | |
| Hydrochloric Acid SCHEMBL648408 | 0.74 | HTR2A (0.35) | — | |
| Hydrochloric Acid SCHEMBL8017987 | 0.74 | HTR6 (0.33) | — | |
| Hydrochloric Acid SCHEMBL7190324 | 0.73 | HTR2A (0.34) | — | |
| Hydrochloric Acid SCHEMBL7518120 | 0.72 | HTR6 (0.32) | — | |
| SCHEMBL6357318 | 0.71 | HTR2A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137384-A1 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | URIGEN PHARMACEUTICALS, INC. | 2023-05-04 | — | — | US | disclosed |
| US-20210283172-A1 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | URIGEN PHARMACEUTICALS, INC. | 2021-09-16 | — | — | US | disclosed |
| EP-1876000-B2 | METHOD OF GRANULATING FLEXIBLE POLYOLEFIN RESIN | IDEMITSU KOSAN CO (JP) | 2020-04-15 | — | — | EP | disclosed |
| EP-3609483-A1 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | Urigen Pharmaceuticals, Inc. (US) | 2020-02-19 | — | — | EP | disclosed |
| WO-2018191412-A9 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | URIGEN PHARMACEUTICALS, INC. (US) | 2019-05-31 | — | — | WO | disclosed |
| WO-2018191412-A1 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | URIGEN PHARMACEUTICALS, INC. (US) | 2018-10-18 | — | — | WO | disclosed |
| EP-1876000-B1 | METHOD OF GRANULATING FLEXIBLE POLYOLEFIN RESIN AND GRANULE | IDEMITSU KOSAN CO (JP) | 2017-01-25 | — | — | EP | disclosed |
| US-7776242-B2 | Method for granulating flexible polyolefin resin and granule | IDEMITSU KOSAN CO., LTD. (JP) | 2010-08-17 | — | — | US | disclosed |
| EP-2192151-A1 | Nucleated propylene polymer compositions and films therefrom | Idemitsu Kosan Co., Ltd. (JP) | 2010-06-02 | — | — | EP | disclosed |
| EP-1006149-B1 | FILMS MADE OF NUCLEATED PROPYLENE POLYMER COMPOSITIONS | IDEMITSU KOSAN CO (JP) | 2009-09-30 | — | — | EP | disclosed |
| EP-0327649-A1 | CATALYST FOR OLEFIN POLYMERIZATION AND PROCESS FOR ITS PREPARATION | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-08-16 | — | — | EP | disclosed |
| EP-0324856-A1 | PROCESS FOR POLYMERIZING OLEFIN | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-26 | — | — | EP | disclosed |
| EP-0314797-A1 | OLEFIN POLYMERIZATION CATALYST AND PROCESS FOR POLYMERIZING OLEFIN | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-05-10 | — | — | EP | disclosed |
| EP-0295312-A1 | SOLID CATALYST FOR OLEFIN POLYMERIZATION AND PROCESS FOR ITS PREPARATION | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-12-21 | — | — | EP | disclosed |
| EP-0294942-A1 | Solid catalyst for polymerizing an olefin | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-12-14 | — | — | EP | disclosed |
| EP-0287666-A1 | PROCESS FOR POLYMERIZING OLEFINS | Mitsui Chemicals, Inc. (JP) | 1988-10-26 | — | — | EP | disclosed |
| EP-0285443-A1 | Process for producing solid catalyst for polymerization of olefins | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-10-05 | — | — | EP | disclosed |
| EP-0283164-A2 | Cyclo-olefinic random copolymer, olefinic random copolymer, and process for producing cyclo-olefinic random copolymers | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-09-21 | — | — | EP | disclosed |
| EP-0279863-A1 | CATALYST FOR POLYMERIZING ALPHA-OLEFIN AND POLYMERIZATION PROCESS | MITSUI CHEMICALS, INC. (JP) | 1988-08-31 | — | — | EP | disclosed |
| EP-0279586-A2 | Finely divided aluminoxane, process for producing same and its use | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210283172-A1 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | OGFR, ALOX5, PTGS1 | ACHE 1647/4885METAP1 3573/4885CHRNB2 1540/4885 |
| US-20230137384-A1 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | OGFR, ALOX5, PTGS1 | ACHE 1647/4885METAP1 3573/4885CHRNB2 1540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.